retatrutide clinical trial dosages Dosage Chart: 2mg to 12mg (Free PDF + Calculator) Retatrutide - PRAMAH / THE

New England Journal of Medicine , 384, 9891002

Tirzepatide, as a dual GLP-1/GIP agonist, may have different gastric effects compared to pure GLP-1 agonists, though evidence remains limited [52]

FDA Recommendations on Storage There is not much information on storage

Patients should remain aware of symptoms such as agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle rigidity, or fever, and seek immediate medical attention if these occur

However, retatrutide is still being studied

Notable Series A funding efforts for new-to-the-scene biotechs with early phase assets include $410 million for Verdiva Bio in 2025 and $400 million for Kailera Therapeutics in late 2024